DYVOX Dynavox Group AB (publ)

STO · SE · Healthcare · Medical Instruments & Supplies · dynavoxgroup.com

73.40SEK-5.47%Mkt Cap: 744.67M $P/E: 34.79Today

Dynavox Group AB (publ), through its subsidiaries, engages in the development and sale of assistive technology products for customers with communication disabilities. The company offers custom designed augmentative and a…

Industry Peers

Medical Instruments & Supplies

Screen all

ISRG

Intuitive Surgical, Inc. - Common Stock

$140.43BUSDP/E 44.8

EssilorLuxottica Société anonyme

$72.05BUSDP/E 27.0

BDX

Becton, Dickinson and Company Common Stock

$48.16BUSDP/E 30.5

MDLN

Medline Inc. - Class A common stock

$47.91BUSDP/E 44.5

RMD

ResMed Inc. Common Stock

Alcon Inc. Ordinary Shares

$30.82BUSDP/E 48.7

WST

West Pharmaceutical Services, Inc. Common Stock

$25.69BUSDP/E 46.8

DIM

Sartorius Stedim Biotech S.A.

$22.21BUSDP/E 69.8

SRT3

Sartorius Aktiengesellschaft

Sartorius Aktiengesellschaft

$15.16BUSDP/E 71.4

SOLV

Solventum Corporation Common Stock

$14.95BUSDP/E 10.7

BAX

Baxter International Inc. Common Stock

$12.14BUSD

COO

The Cooper Companies, Inc. - Common Stock

$10.82BUSDP/E 19.6

AVTR

Avantor, Inc. Common Stock

$10.38BUSD

COO

The Cooper Companies, Inc.

$10.29BUSDP/E 18.6

RGEN

Repligen Corporation - Common Stock

$10.25BUSDP/E 248.9

ALGN

Align Technology, Inc. - Common Stock

$10.21BUSDP/E 25.0

ATR

AptarGroup, Inc. Common Stock

$7.62BUSDP/E 21.6

Key Statistics

Company

Market Cap744.67M USD

Enterprise Value883.81M USD

Revenue (TTM)242.96M USD

Gross Profit161.48M USD

Net Income (TTM)15.85M USD

Revenue/Share24.07 SEK

Last Price73.40 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees1.1K

CountrySE

SectorHealthcare

IndustryMedical Instruments & Supplies

ISINSE0017105620

Valuation

P/E (Trailing)34.79

P/E (Forward)36.98

PEG—

EV/EBITDA19.91

EV/Revenue3.64

P/S3.24

P/B11.72

EPS (TTM)2.11

EPS (Forward)2.10

52W Range

57.2026% of range118.70

52W High118.70 SEK

52W Low57.20 SEK

Profitability

Gross Margin68.43%

Oper. Margin15.67%

EBITDA Margin18.27%

Profit Margin6.72%

ROE27.51%

ROA6.70%

Growth

Revenue Growth11.10%

Earnings Growth155.60%

Cash Flow & Leverage

Operating CF18.81M USD

CapEx (TTM)19.60M USD

FCF Margin7.02%

FCF Yield2.29%

Net Debt84.37M USD

Net Debt/EBITDA1.90

Balance Sheet

Debt/Equity1.83

Current Ratio1.59

Quick Ratio1.08

Book Value/Sh6.62 SEK

Cash/Share2.07 SEK

Dividends

Fwd Div Rate0.50 SEK

Trail. Div Rate0.50 SEK

Div. Yield0.64%

5Y Avg Yield—

Payout Ratio23.70%

Ex-Div DateMay 11, 2026

Pay Date—

Analyst Consensus

Rating1.5 (Buy)

Strong BuyBuyHoldSellStr. Sell

Target (Mean)112.60 SEK

Upside (mean)+53.4%

Target Range90.00 SEK – 140.00 SEK

90.00+53.4% to mean140.00

# Analysts5

Ownership

Shares Out.106.07M

Float101.37M

Insiders4.34%

Institutions74.28%

Technical

SMA 5074.75 (-1.8%)

SMA 20080.45 (-8.8%)

Beta0.81

S&P 52W Chg14.58%

Avg Vol (30d)181.56K

Avg Vol (10d)202.33K

Technical Indicators

RSI (14)57.9

MACD0.5101

MACD Signal0.3111

MACD Hist.+0.1990

BB Upper77.91 SEK

BB Middle74.67 SEK

BB Lower71.43 SEK

BB Width8.69%

ATR (14)2.663 SEK

Vol Ratio (20d)0.80x